India, Nov. 30 -- image credit- shutterstock

A major trend in 2025 was the rise of anti-obesity drugs. Mounjaro, in particular, saw rapid uptake and became the second-highest selling weight-loss drug in India within just six months.

Another highlight was the opening of several Centres of Excellence (CoE). Notably, Miltenyi Biotec inaugurated India's first Cell and Gene Therapy (CGT) CoE in Hyderabad, reflecting the growing focus on advanced therapies.

Much like everything in life, artificial intelligence (AI) continued to deepen its presence across healthcare, transforming diagnostics, research, and drug development.

Pharma and Biotech

Policy and Innovation Driving Advanced Therapies

The Government of India has launched the 'Promoti...